Samjin Pharmaceuticals Co., Ltd. (KRX:005500)
South Korea · Delayed Price · Currency is KRW 19,340
+70 (0.36%)
At close: Oct 2, 2025
Samjin Pharmaceuticals Market Cap
Samjin Pharmaceuticals has a market cap or net worth of 237.07 billion as of October 6, 2025. Its market cap has increased by 2.53% in one year.
Market Cap
237.07B
Enterprise Value
n/a
Revenue
274.03B
Ranking
n/a
PE Ratio
11.19
Stock Price
19,340.00
Market Cap Chart
Since August 30, 1995, Samjin Pharmaceuticals's market cap has increased from 29.12B to 237.07B, an increase of 714.10%. That is a compound annual growth rate of 7.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 237.07B | 6.97% |
| Dec 30, 2024 | 221.61B | -19.69% |
| Dec 28, 2023 | 275.94B | -19.80% |
| Dec 29, 2022 | 344.07B | 5.06% |
| Dec 30, 2021 | 327.51B | -3.49% |
| Dec 30, 2020 | 339.34B | 9.22% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |